Patients & Visitors

Rheumatology

F8

Consultants

 

Meet the team

Consultants

Dr Raj Sengupta

Professor Raj Sengupta, MBBC, PGCME, FRCP

Consultant Rheumatologist
Visiting Professor at the University of Bath
Clinical Lead

Professor Raj Sengupta is a Consultant Rheumatologist and Lead for Ankylosing Spondylitis at The Royal National Hospital for Rheumatic Diseases, Bath (RNRHD).

He is a member of the BSR Spondyloarthritis Special Interest Group, the BSR axSpA Biologics Guidelines Committee and a member of ASAS (Assessment of Spondyloarthritis International Society).

He has represented the BSR at the NICE TA383 appraisal for anti TNF in AxSpA. Professor Sengupta is a medical advisor for the National Ankylosing Spondylitis Society (NASS) and is one of the founder members of BRITSpA. Professor Sengupta was the recipient of the 2016 NASS Patients Choice award for the Best care provided by a Rheumatologist.

He is the principal investigator in several national and international clinical trials in axial Spondylarthritis.

He has a number of peer reviewed publications on axSpA. Professor Sengupta has been an invited speaker on axSpA at several national and international meetings.

A full list of publications is available at:

Secretary: Julie Anscombe


Dr Tehseen Ahmed

Dr Tehseen Ahmed, MBChB, MRCP (Rheum)

Consultant Rheumatologist

Dr Tehseen Ahmed is a consultant in rheumatology and has a special interest in osteoporosis and metabolic bone disease. Dr Ahmed undertook his medical training in Birminham and completed his Rheumatology training in the Severn region.

He is a member of the British Society for Rheumatology, the National Osteoporosis Society, and the American Society for Bone and Mineral Research. He has an interest in medical education and leads Rheumatology teaching for medical students from the University of Bristol. He currently runs general rheumatology, osteoporosis, and joint/soft tissue injection clinics.

Secretary: Julie Anscombe


Dr Andrew Allard

Dr Andrew Allard MBBS, MA (Cantab), MRCP (Rheum)

Consultant Rheumatologist

Dr Andrew Allard is a consultant rheumatologist with subspecialty interests in rheumatoid arthritis, psoriatic arthritis and musculoskeletal ultrasound. He attended Cambridge University and University College London during his medical training and completed his rheumatology training in the Severn region.

He runs clinics in general rheumatology, early inflammatory arthritis, psoriatic arthritis and musculoskeletal ultrasound. He is currently the departmental lead for rheumatoid arthritis.

Dr Allard has a strong interest in medical education. He is the post-graduate education lead for rheumatology and is the clinical representative on the Education and Engagement Committee for the Bath Institute for Rheumatic Diseases (BIRD).

He has further interests in quality improvement and service development and has published research in the field of psoriatic arthritis. He is a principle investigator on clinical studies in rheumatoid arthritis. He is a member of the British Society for Rheumatology and the Royal College of Physicians.

Secretary: Sarah Cotton


Dr Victoria Flower

Dr Victoria Flower MBBS, BSc, PhD, MRCP (Rheum)

Consultant Rheumatologist

Dr Flower is a Rheumatology consultant with a specialist interest in connective tissue diseases including Systemic sclerosis and Sjogren's syndrome.

She completed her medical degree at Imperial College School of Medicine in 2007 and subsequently worked in London before relocating to the southwest of England. She undertook her doctoral research at the University of Bath investigating blood vessel and skin changes in Systemic sclerosis.

Dr Flower was appointed as a consultant Rheumatologist at the RNHRD in November 2020. She leads a specialist service for patients with Systemic sclerosis, providing care for patients who live locally as well as being a tertiary referral centre for patients around the UK. The service benefits from a number of specialised microvascular imaging techniques and extended autoantibody tests that allows for early diagnosis of Scleroderma spectrum disorders. Within the team, our specialist nurses are able to help with conservative strategies for symptom control, medication education and practical advice. Dr Flower works collaboratively with the regional Pulmonary Hypertension service at the RUH to provide patients with combined expertise and a multidisciplinary team approach.

Dr Flower holds a visiting Senior Lecturer position at the University of Bath. She is a member of the international Scleroderma Clinical Trials Consortium and the UK Scleroderma Study Group. She has published original research and book chapters in the field of Raynaud's phenomenon and Systemic sclerosis. She has a particular research interest in advancing the clinical use of ultrasound and microvascular imaging techniques to improve the way we assess and manage Rheumatic diseases.

The service actively engages in research to improve the way we treat patients with rare diseases. Dr Flower is keen for patients to have the opportunity to participate in research. She is the Principle investigator for a number of national and international trials at the RNHRD including observational studies and drug trials.

Secretary: Beverley Satchell


Dr Sarah Hardcastle

Dr Sarah Hardcastle MBChB, BSc, PhD, MRCP (Rheum)

Consultant Rheumatologist

Dr Hardcastle was appointed as a Consultant Rheumatologist at the RNHRD in July 2018, having previously trained in the area. As well as general rheumatology, she has a specialist interest in osteoporosis and metabolic bone disease, having completed a PhD examining the relationship between osteoarthritis and high bone density.

She is the current co-convenor of the British Society for Rheumatology's osteoporosis Special Interest group.

Secretary: Sarah Cotton


Dr Ellie Korendowych

Dr Ellie Korendowych MA, MBBCh, PhD, FRCP

Consultant Rheumatologist

Dr Korendowych qualified in Natural sciences from Cambridge University before completing her degree in Medicine at Oxford University. She trained in Rheumatology in Bristol and Bath before undertaking her PhD in the Immuno-genetics of Psoriatic arthritis (PsA) in Bath and Australia. She was appointed as a Consultant at the Royal National Hospital for Rheumatic Diseases in Bath in 2005 and was Clinical Lead for the department from 2007-2019 and medical director of the RNHRD in 2014.

She has a longstanding clinical and research interest in PsA and established one of the country's first dedicated PsA biologics clinics in 2006, which continues to receive referrals from across the UK. Her main interests are in biologic therapy, outcome measures and the genetics of Psoriatic Arthritis.

She has been a member of the PsA European Genetics Consortium, GRAPPA and BRITPACT and has been an expert for the British Society of Rheumatology in NICE technology appraisals in PsA for over 10 years. She is a Principal Investigator for several national and international clinical trials in PsA. Her other main clinical and research interest is in autoimmune connective tissue disorders particularly Lupus.

She leads a specialist Lupus clinic alongside the multi-disciplinary team and together with colleagues is continuing to build a successful research and clinical trials programme in Lupus in Bath. The team at the RNHRD were recently recognised by Lupus UK as a Centre of Excellence for Lupus.

Secretary: Debra Morris


Dr Chloe Lapraik

Dr Chloe Lapraik MBchB, MRCP (Rheum)

Consultant Rheumatologist

Dr Chloe Lapraik is a consultant in rheumatology and has a special interest in early inflammatory arthritis and rheumatoid arthritis. She trained at Liverpool medical school and completed her specialist training in rheumatology in the Eastern Deanery.

Dr Lapraik is the first author for the British Society for Rheumatology first guideline for the management of adults with ANCA associated vasculitis. She is the lead for the early inflammatory arthritis service at the Royal National Hospital for Rheumatic diseases, Bath (RNHRD) and is a member of the British society for rheumatologists.

Secretary: Glynis Vincent


Dr Sarah Skeoch

Dr Sarah Skeoch BSc, MBChB (hons), MSc, PhD, MRCP (Rheum)

Consultant Rheumatologist

Sarah Skeoch joined the team as a consultant rheumatologist in 2018. She completed her rheumatology training in The North West of England, where she undertook a Masters in Clinical Rheumatology, a PhD studying cardiovascular disease in rheumatoid arthritis and a Clinical Lectureship in Rheumatology and Clinical Pharmacology at the University of Manchester.

Our department is a Lupus UK Centre of Excellence and a Vasculitis Specialist Centre. Sarah leads the vasculitis service and co-leads the lupus service. She oversees a dedicated giant cell arteritis fast track service, which has been highlighted as an area of good practice by British Society for Rheumatology peer review programme.

She manages the department's CTD/vasculitis Multi-disciplinary team meeting, which in attended by doctors from different medical specialties, specialist nurses, pharmacist and therapists. The MDT oversees the prescription of specialist biologic medications and management of particularly complex cases. She is also part of regional, national and international networks for lupus and vasculitis.

She maintains an active research interest, being involved in both national and international research projects. Her research focuses on outcomes in connective tissue disease, comorbidity in rheumatic diseases and translational imaging.

She is a Visiting Senior Lecturer at the University of Bath and holds an Honorary Clinical Lecturer position at the University of Manchester. She is a member of the British Society for Rheumatology, Royal College of Physicians and the British Isles Lupus Assessment Group (BILAG). She also sits on the Bath Institute for Rheumatic Diseases Research Committee.

Secretary: Beverley Satchell


Dr Sarah Tansley

Dr Sarah Tansley BSc MBChB PhD MRCP (Rheum)

Consultant Rheumatologist

Dr Sarah Tansley is a Consultant Rheumatologist and Senior Clinical Lecture in Pharmacy and Pharmacology at the University of Bath. She undertook her medical training at the University of Edinburgh and worked in both Scotland and New Zealand before moving to Bath in 2010. She completed her rheumatology training locally, in addition to a PhD at the University of Bath.

Dr Tansley's research focuses on the autoimmune connective tissue diseases, particularly myositis. She is a member of the International Myositis Assessment and Clinical Studies group and the British Society of Rheumatology. She is a co-author of the British Society of Rheumatology (BSR) myositis treatment guidelines, due to be published later in 2021, and lecturers on immunological tests on the BSR core skills in rheumatology course.

Dr Tansley has a clinical interest in the autoimmune connective tissues diseases in addition to young adult and adolescent rheumatology. She established our local fast track giant cell arteritis assessment pathway and also runs an autoimmune connective tissue diseases clinic and the young adult rheumatology clinic.

Dr Tansley runs our dedicated transition clinic alongside paediatric rheumatology specialist Dr Valerie Rogers. Together they review paediatric rheumatology patients preparing to move into the adult rheumatology service, to ensure continuity of care and a smooth transition.

Secretary: Glynis Vincent


Dr William Tillett

Dr William Tillett BSc, MBChB, PhD, FRCP

Consultant Rheumatologist

Dr William Tillett is a consultant rheumatologist at the Royal National Hospital for Rheumatic Diseases and senior lecturer in the Department of Pharmacy and Pharmacology at the University of Bath, UK. William graduated from the University of Bristol with a BSc in Anatomical Science before undertaking his medical degree at the same institution. He undertook his doctoral fellowship in outcome measurement in psoriatic arthritis.

His clinical and research interests centre on improving the lives of people living with rheumatic conditions with a special focus on Psoriatic Arthritis. His primary research centres on early detection, improved assessment, novel treatments and precision medicine. He is the chief investigator or principle investigator on a number of national and international clinical trials and has published more the 150 original research articles, guidelines, conference proceedings and book chapters on psoriatic arthritis.

Dr Tillett currently chairs the British Society of Rheumatology (BSR) treatment guideline group and European chair of the International group for assessments of psoriatic Arthritis (OMERACT). He is a trustee for the Bath Institute for Rheumatic Diseases (BIRD) and the British Psoriatic Arthritis consortium (BritPACT) and is an advisor to numerous other research organisations and arthritis charities including PAPAA, GRAPPA and Versus Arthritis.

Outside work William enjoys family life, woodwork, forging, cycling and dachunds.

A full list of publications is available at:

Secretary: Debra Morris



back to top